SYNAGIS
SYNAGIS
Approved
DIN Number
02438372
Drug Class
Human
Market Date
Nov 3, 2016
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02438372
AIG Number0147401002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
J06BD01 PALIVIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification08:18.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
PALIVIZUMABActive
Strength: 50 MG / 0.5 ML
Monograph: PALIVIZUMAB